TP53 and breast carcinoma: The oncogene, C-erbB2, and tumor suppressor, P53, play vital roles in breast cancer treatment and prognosis [25]; aberrant C-erbB2 expression and P53 mutation can lead to tumor metastasis, insensitivity to endocrine treatment and poor prognosis [26].